The targeted localization of maximal concentrations of the therapeutic to the cellular/subcellular site of action in pathologically damaged tissues is one of the recurring obstacles in therapeutic drug delivery. Small molecule medications lack tissue and organ selectivity, have quick in vivo body clearance, and are frequently associated with a slew of adverse effects, particularly chemotherapeutic treatments, which are extremely toxic. Drug delivery systems (DDS) have been employed as one of the most promising solutions to solve this issue in recent decades. Cell-mediated DDS has emerged as a promising technique for addressing the aforementioned issues in recent years. Cell-mediated DDS has emerged as a new branch of therapy that allows for tailored distribution, increased circulation time, and decreased cellular and tissue toxicity. Intracellular delivery/therapy is a critical topic that will pique people's curiosity. Because the drug is not provided externally within the bloodstream, intracellular delivery allows for far more efficient drug delivery because the impact (on various organelles and locations) is intracellular. Targeted delivery with increased localized delivery and efficacy has a lot of potential.
- Drug Targeting and Design
- Targeted Drug Delivery System
- Tissue Specific Drug Delivery
A C Matin
Stanford University School of Medicine, Canada
Consolato M Sergi
University of Ottawa, Canada
Sergey Suchkov
University of Medicine & Dentistry, Russian Federation
Hans Christian Siebert
Research Institute of Bioinformatics and Nanotechnology (RIBNT), Germany
Ekaterina Aleksandrovna Pashkina
Research Institute of Fundamental and Clinical Immunology, Russian Federation
Swati Sachin Mutha
Vishwakarma University, India
Phila Raharivelomanana
University of French Polynesia, French Polynesia
Mridula Prakash Menon
National Ilan University, Taiwan
Jian Yu Chen
Fujian University of Traditional Chinese Medicine, China
Naseratun Nessa
Kyoto Prefectural University of medicine, JapanSubmit your abstract Today
Title : mRNA and exosome-mediated directed gene therapy of cancer with no side effects
A C Matin, Stanford University School of Medicine, Canada
Title : Assessment of Marquesan Rauvolfia nukuhivensis bioactive content
Phila Raharivelomanana, University of French Polynesia, French Polynesia
Title : Antibody-Proteases as Translational Tools of The Newest Generation to be applied for Biodesign and Bioengineering to get Precision and Personalized Healthcare Services Re-armed
Sergey Suchkov, University of Medicine & Dentistry, Russian Federation
Title : Nano modification of Antrodia cinnamomea exhibit anti-inflammatory action and improves the migratory potential of myogenic progenitors
Mridula Prakash Menon, National Ilan University, Taiwan
Title : Preparation and Optimization of Oral Lyophilized Flash Tablets Loaded with Sildenafil Citrate Self Nanoemulsifying System
Maeen Abdulaziz Almodhwahi, King Abdulaziz University, Saudi Arabia
Title : The Discovery of the First Red Geopolymer
Kawkab Kh al Naimi, Qatar University, Qatar
Title : Preliminary studies on phytochemical constituents of the leaves and fruits of Annona atemoya
Bassam Alkazman, The University of Sydney, Australia
Title : Selectively Inhibition of Magnolol on Th17 Cell Differentiation both in vitro and in vivo through Blocking STAT3 Signaling in CD4+ T Cells via Specifically Binding to STAT3 at SH2 Domain for Treating Multiple Sclerosis
Jian Yu Chen, Fujian University of Traditional Chinese Medicine, China
Title : Needles of Cupressus torulosa D. Don ex Lamb as a sustainable antioxidant and antidiabetic drug material
Radhika khanna, Forest Research Institute, India
Title : Targeted Vesicular Drug Delivery Insight
Swati Sachin Mutha, Vishwakarma University, India